Trials / Completed
CompletedNCT00198146
Prevention of Diabetes Progression Trial (PDPT)
PD Initiated/Prevention of Diabetes Progression Trial (PDPT) ZEN119
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- Indiana University School of Medicine · Academic / Other
- Sex
- All
- Age
- 2 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to determine the efficacy and safety of daclizumab in preventing the progression of diabetes in children who have just been diagnosed with type I diabetes. Additional purposes of the study are to investigate the amount of drug in the children, how quickly it is eliminated from the blood, and analyze the effect of the drug on the immune reaction to diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zenapax |
Timeline
- Start date
- 2000-07-01
- Primary completion
- 2007-02-23
- Completion
- 2007-02-23
- First posted
- 2005-09-20
- Last updated
- 2020-08-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00198146. Inclusion in this directory is not an endorsement.